Non-invasive Mechanical Ventilation After Cardiac Surgery

This study has been completed.
Sponsor:
Collaborator:
Federal University of Rio Grande do Sul
Information provided by (Responsible Party):
Alessandra Preisig, Irmandade Santa Casa de Misericórdia de Porto Alegre
ClinicalTrials.gov Identifier:
NCT01457898
First received: October 19, 2011
Last updated: October 21, 2011
Last verified: October 2011
  Purpose

Non-invasive mechanical ventilation (NIV) has been used in hypoxic post-operative cardiac patients but more studies are necessary to clarify its respiratory and hemodynamic effects. Therefore, the investigators objective was to study its effects in the oxygenation index (PaO2/FiO2) and in hemodynamic variables in this group of patients.


Condition Intervention
Heart; Dysfunction Postoperative, Cardiac Surgery
Device: VPAP II®

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Effects of Non-invasive Mechanical Ventilation on Hemodynamics and Gas Exchanges Parameters After Cardiac Surgery in Patients With Relative Hypoxemia

Resource links provided by NLM:


Further study details as provided by Irmandade Santa Casa de Misericórdia de Porto Alegre:

Primary Outcome Measures:
  • Oxygenation index (PaO2/FiO2) [ Time Frame: 5 hours ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Heart rate (HR) [ Time Frame: 5 hours ] [ Designated as safety issue: Yes ]
  • Mean arterial pressure (MAP) [ Time Frame: 5 hours ] [ Designated as safety issue: Yes ]
  • Pulmonary capillary wedge pressure (PCWP) [ Time Frame: 5 hours ] [ Designated as safety issue: Yes ]
  • Cardiac output (CO) [ Time Frame: 5 hours ] [ Designated as safety issue: Yes ]

Enrollment: 42
Study Start Date: April 2008
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: VPAP II®
VPAP II® Group
Device: VPAP II®
VPAP group:inspiratory pressure to generate 6ml/kg of weight and expiratory pressure of 7cmH2O plus oxygen therapy (FIO2=40%) during three hours.
Other Name: VPAP II -STA (Resmed®)

Detailed Description:
  • Postoperative cardiac surgery patients having a Swan-Ganz catheter and showing a PaO2/FiO2 between 150 and 300 (with FIO2 0.31), one hour after extubation, were included.
  • Then, the patients were randomized into two groups: control and intervention group. Intervention group used NIV with a bi-level positive airway pressure (an inspiratory pressure to generate a tidal volume of 6ml/kg and an expiratory pressure of 7cmH2O) with a FIO2 0.4. Control group used oxygen by Venturi mask(FIO2 0.4) in order to keep a good oxygenation.
  • In both groups measurements were done in basal situation, one and three hours after beginning the treatment and one hour after stop the treatment (FiO2 0.31).
  • Variables studied included: PaO2/FiO2, PaO2, PaCO2, heart rate (HR), mean arterial pressure (MAP), pulmonary capillary wedge pressure (PCWP) and cardiac output (CO).
  Eligibility

Ages Eligible for Study:   20 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Oxygenation index (PaO2/FiO2)between 150 and 300 one hour after extubation following cardiac surgery.
  • Swan-Ganz catheter

Exclusion Criteria:

  • Invasive mechanical ventilation more than 24 hours
  • Serious obstructive pulmonary chronic disease (FEV1<40%)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01457898

Locations
Brazil
Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90020-090
Sponsors and Collaborators
Irmandade Santa Casa de Misericórdia de Porto Alegre
Federal University of Rio Grande do Sul
Investigators
Principal Investigator: Alessandra P Werlang, MsC Federal University of Rio Grande do Sul
  More Information

No publications provided

Responsible Party: Alessandra Preisig, Principal Investigator, Irmandade Santa Casa de Misericórdia de Porto Alegre
ClinicalTrials.gov Identifier: NCT01457898     History of Changes
Other Study ID Numbers: 1751/07
Study First Received: October 19, 2011
Last Updated: October 21, 2011
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Irmandade Santa Casa de Misericórdia de Porto Alegre:
Cardiac surgery
Non-invasive ventilation

ClinicalTrials.gov processed this record on July 22, 2014